EGFR and head and neck squamous cell carcinoma: The study conducted by Johansson et al. for HNSCC used a co-culture model similar to other reports in the literature to show that HNSCC and CAF co-cultured lines were resistant to cetuximab treatment, which is an EGFR antagonist.